HCW Biologics Inc. (NASDAQ:HCWB – Get Rating) was the recipient of a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 27,600 shares, an increase of 10.8% from the March 31st total of 24,900 shares. Based on an average trading volume of 18,000 shares, the […]
EF Hutton Acquisition Co. I reiterated their buy rating on shares of HCW Biologics (NASDAQ:HCWB – Get Rating) in a report published on Wednesday, Benzinga reports. EF Hutton Acquisition Co. I currently has a $9.00 price objective on the stock. HCW Biologics Stock Performance Shares of HCWB stock opened at $1.39 on Wednesday. The company […]
HCW Biologics Inc. (NASDAQ:HCWB – Get Rating) was the target of a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 24,900 shares, an increase of 11.7% from the March 15th total of 22,300 shares. Approximately 0.1% of the shares of the stock are sold […]
HCW Biologics Inc. (NASDAQ:HCWB – Get Rating) was the target of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 24,900 shares, an increase of 11.7% from the March 15th total of 22,300 shares. Currently, 0.1% of the company’s stock are short sold. Based […]